Details for New Drug Application (NDA): 088304
✉ Email this page to a colleague
NDA 088304 describes DIBENIL, which is a drug marketed by Cenci and is included in one NDA. Additional details are available on the DIBENIL profile page.
The generic ingredient in DIBENIL is diphenhydramine hydrochloride. There are twenty-three drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.
The generic ingredient in DIBENIL is diphenhydramine hydrochloride. There are twenty-three drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.
Summary for 088304
| Tradename: | DIBENIL |
| Applicant: | Cenci |
| Ingredient: | diphenhydramine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 088304
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | ELIXIR;ORAL | Strength | 12.5MG/5ML | ||||
| Approval Date: | Dec 16, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
